Jump to search

May 2021

UC Davis Health now enrolling children ages 12-17 for Novavax coronavirus vaccine trial

May 7, 2021

UC Davis Health will soon launch a stage 3 clinical trial for a new coronavirus vaccine for children ages 12-17 with the National Institutes of Health (NIH) and Novavax. The two-year study aims to enroll 100 participants.

April 2021

Calibrating Lactoferrin protein in milk may boost learning and protect neurons

April 29, 2021

Lactoferrin is a glycoprotein found naturally in breast milk. A study by UC Davis Professor Fredric A. Troy II found that the lactoferrin concentration in the diet has significantly different impacts on learning, brain development and neuroprotection.

PsychLight sensor to enable discovery of new psychiatric drugs

April 28, 2021

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

Promising gene therapy for Duchenne muscular dystrophy

April 28, 2021

Clinical researchers at UC Davis Health are using an innovative gene therapy approach for Duchenne muscular dystrophy, which the lead physician hopes will be a transformational treatment for children with the disease.

Celebrating translational science researchers at UC Davis

April 23, 2021

During its 16th annual CTSC Scholar Symposium, UC Davis celebrated the graduation of its newest cohort of scholars who conduct innovative applied health research.

MIND Institute study of anxiety in children with autism now includes online treatment

April 20, 2021

The UC Davis MIND Institute is now offering online treatment as part of its clinical trial known as the STAAR study. The trial will compare the effectiveness of the medication sertraline and cognitive behavioral therapy in treating anxiety in children with autism.

New test to study language development in youth with Down syndrome

April 8, 2021

A team led by UC Davis Health researchers tested and validated a new set of procedures for collecting, measuring and analyzing the spoken language of youth with Down syndrome in a naturalistic setting.

March 2021

Nexplanon birth control study seeks participants

March 9, 2021

UC Davis Health is now enrolling women in a new study to extend Nexplanon’s use to five years. Nexplanon is a contraceptive implant that is inserted under the skin of the upper arm to provide birth control. The implant is currently approved for three years of use.  

New research seeks to reduce birth injury causing shoulder, arm and hand paralysis

March 9, 2021

New study evaluates maternal and hospital factors possibly linked to risk of brachial plexus birth injury, the leading cause of infants’ upper extremity paralysis.

Enhancing California’s specialty crops

March 4, 2021

UC Davis’ Center for Precision Medicine and Data Sciences will be helping to enhance the competitiveness of California’s specialty crops thanks to a new grant.

First stem cell clinical trial for spina bifida treatment announced

March 1, 2021

A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.